Cancer :: Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials

Oncolytics Biotech Inc. (“Oncolytics”) (TSX:ONC, NASDAQ:ONCY) announced that an oral presentation covering interim results from a U.K. Phase Ia/Ib combination REOLYSIN® and radiation clinical trial for patients with advanced or metastatic cancers is scheduled to be presented at the National Cancer Research Institute (NCRI) conference on October 2, 2007 in Birmingham, U.K.

Health :: Rice unveils $100 million initiative for world health technology

Rice University today unveiled plans for a $100 million initiative to create an institute to develop technologies to combat pressing health problems in the developing world, such as HIV/AIDS and child mortality. The initiative was announced today during the annual meeting of the Clinton Global Initiative in New York.

Meditation :: Meditation therapy for rheumatoid arthritis patients

A revered contemplative practice for centuries, meditation has recently inspired research into its therapeutic value for everything from anxiety disorders to heart attack prevention. A painful, progressive autoimmune disease, rheumatoid arthritis (RA) is associated with a high risk of depression—double the risk of the healthy population, by conservative estimates—and various forms of psychological distress.

Depression :: Genes linked to suicidal thinking during antidepressant treatment

Specific variations in two genes are linked to suicidal thinking that sometimes occurs in people taking the most commonly prescribed class of antidepressants, according to a large study led by scientists at the National Institutes of Health’s (NIH) National Institute of Mental Health (NIMH). Depending on the particular mix inherited, these versions increased the likelihood of such thoughts from 2- to15-fold, the study found.

Infant :: New approach to improving diarrhea in infants with probiotics

Each year more than half a million infants worldwide, primarily in developing countries, die from diarrhea caused by rotavirus. Even in industrialized countries management of the infection costs economies about $1 billion a year. Now a study in the online open access journal, BMC Microbiology demonstrates that with the addition of probiotic bacteria, preventative measures can potentially be made far cheaper but just as effective.

RNA :: Team demos safety of RNA therapy

Researchers from MIT, Alnylam Pharmaceuticals and other institutions have demonstrated the safety of a promising type of genetic therapy that could lead to treatments for a wide range of diseases such as cancer.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack